3 results match your criteria: "University of Arkansas Medical Sciences College of Medicine[Affiliation]"

Mental health and humanitarian crisis: Moral stress in trauma therapy.

Bioethics

November 2024

Department of Medical Humanities and Bioethics, University of Arkansas Medical Sciences College of Medicine, Little Rock, Arkansas, USA.

This article offers a narrative analysis of the contributing factors of moral distress (MD) and moral injury (MI) among mental health clinicians working amidst humanitarian crises. It discusses the impact of moral stress on therapeutic relationships in mental health trauma. The article originated from the author's experience developing a peer-to-peer support program at a nongovernmental organization (NGO) and conducting peer-to-peer support for mental health clinicians and healthcare providers in Ukraine and Turkey.

View Article and Find Full Text PDF

This study investigated the direct roles of hydrogen peroxide (H O ) in kidney aging using transgenic mice overexpressing glutathione peroxidase-1 (GPX1 TG). We demonstrated that kidneys in old mice recapitulated kidneys in elderly humans and were characterized by glomerulosclerosis, tubular atrophy, interstitial fibrosis, and loss of cortical mass. Scavenging H O by GPX1 TG significantly reduced mitochondrial and total cellular reactive oxygen species (ROS) and mitigated oxidative damage, thus improving these pathologies.

View Article and Find Full Text PDF

Myeloma and bone disease: "the dangerous tango".

Clin Adv Hematol Oncol

April 2006

Myeloma Institute for Research and Therapy, University of Arkansas Medical Sciences College of Medicine, Little Rock, AR 72205, USA.

Osteolytic bone disease is the most debilitating manifestation of myeloma. However, myeloma-induced effects on the bone-active cells in the bone marrow are more than just a manifestation of disease--the myeloma derives essential support from the changed balance between bone-forming and -resorbing cells. This observation has lead to the notion that effective control of myeloma bone disease by reducing osteoclast activity and restoring osteoblast activity will contribute to long-term control of myeloma progression.

View Article and Find Full Text PDF